This is a routine insider intent-to-sell filing by a director. The dollar amount is immaterial relative to market cap. No immediate trading action warranted. Monitor for any subsequent Form 4 filings to confirm execution.
COLL drugs
COLL drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 11 $35.81entry
- T+1 · 6mo ago −0.34%α −0.20% · $35.69
- T+5 · 6mo ago −6.03%α −5.95% · $33.65
- T+20 · 5mo ago −3.94%α −3.63% · $34.40
- T+60 · 3mo ago −0.20%α −4.59% · $35.74
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Garen G. Bohlin filed a Form 144 notice of intent to sell 8,700 shares of Collegium Pharmaceutical common stock, valued at approximately $323,491. The sale is planned through Fidelity Brokerage Services LLC and relates to shares acquired via a 2016 option grant.
Key Facts
- Director Garen G. Bohlin filed Form 144 to sell 8,700 shares.
- Estimated sale value: $323,491.
- Shares relate to a 2016 option grant.
- Sale to be executed through Fidelity Brokerage Services LLC.
- Filing date: May 11, 2026.
Financial Impact
Sale of 8,700 shares valued at ~$323,491, representing a small fraction of the company's $1.2B market cap.
Risk Factors
- Insider selling may signal lack of confidence, but this is a small, routine sale by a director, not a C-suite officer.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-003457 |
| Document: 0001959173-26-003457-index.html | 0001959173-26-003457 |
| Document: 0001959173-26-003457.txt | 0001959173-26-003457 |
Track record
24 reports on COLL
1 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +0.28% at T+1 after the Aug 13, 2026 report. 1 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $25.68 Now $25.43 −0.97% settles Nov 17
- Nov 10, 20266d ago SC 13G/A Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $24.47 to $24.81 Now $25.43 +3.92% ▲ +1.39% +0.07% vs SPY
- Nov 9, 20267d ago Institutional Cluster Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Neutral 5/10 Entry $25.16 to $24.21 Now $25.43 +1.07% ▼ −3.78% −4.09% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $23.80 to $23.68 Now $25.43 +6.85% ▼ −0.50% −0.03% vs SPY
- Oct 29, 202618d ago SC 13G/A Neutral 3/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
- Oct 29, 202618d ago Press Release Neutral 2/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $23.50 to $22.96 Now $25.43 +8.21% ▼ −2.30% −1.78% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers